1. Home
  2. HYNE vs RPID Comparison

HYNE vs RPID Comparison

Compare HYNE & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hoyne Bancorp Inc.

HYNE

Hoyne Bancorp Inc.

N/A

Current Price

$16.31

Market Cap

124.9M

Sector

Finance

ML Signal

N/A

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$2.11

Market Cap

102.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYNE
RPID
Founded
2025
2006
Country
United States
United States
Employees
61
N/A
Industry
Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.9M
102.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HYNE
RPID
Price
$16.31
$2.11
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
5.4K
211.4K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
2.78
EPS
N/A
N/A
Revenue
N/A
$33,587,000.00
Revenue This Year
N/A
$19.12
Revenue Next Year
N/A
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.74
52 Week Low
$13.56
$1.66
52 Week High
$16.86
$4.94

Technical Indicators

Market Signals
Indicator
HYNE
RPID
Relative Strength Index (RSI) 46.17 56.83
Support Level $16.31 $2.07
Resistance Level $16.86 $2.17
Average True Range (ATR) 0.17 0.11
MACD -0.04 0.00
Stochastic Oscillator 25.00 50.00

Price Performance

Historical Comparison
HYNE
RPID

About HYNE Hoyne Bancorp Inc.

Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: